DeSUMOylation controls insulin exocytosis in response to metabolic signals

Biomolecules

Volumn 2, Issue 2, 2012, Pages 269-281

  Vergari, Elisa ^a   Plummer, Gregory ^b   Dai, Xiaoqing ^b   MacDonald, Patrick E ^b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Exocytosis; Insulin; NADPH; Redox; SENP1; SUMOylation

Indexed keywords

INSULIN; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SENP1 PROTEIN; SHAB POTASSIUM CHANNEL; SUMO 1 PROTEIN; SUMO PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; DESUMOYLATION; ELECTROPHYSIOLOGY; EXOCYTOSIS; HUMAN; IMMUNOBLOTTING; INSULIN RELEASE; MALE; NONHUMAN; OXIDATION REDUCTION STATE; PANCREAS ISLET BETA CELL; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; SECRETORY PATHWAY; SUMOYLATION; SYNAPTIC TRANSMISSION; WESTERN BLOTTING;

EID: 85016380899     PISSN: None     EISSN: 2218273X     Source Type: Journal    
DOI: 10.3390/biom2020269     Document Type: Article

References (50)

1. Kahn, S.E. The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus. Am. J. Med. 2000, 108 (Suppl. 6a), 2S-8S.
2. Henquin, J.C. The dual control of insulin secretion by glucose involves triggering and amplifying pathways in beta-cells. Diabetes Res. Clin. Pract. 2011, 93 (Suppl. 1), S27-S31.
3. Henquin, J.C. Regulation of insulin secretion: A matter of phase control and amplitude modulation. Diabetologia 2009, 52, 739-751.
4. MacDonald, P.E.; Joseph, J.W.; Rorsman, P. Glucose-sensing mechanisms in pancreatic beta-cells. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2005, 360, 2211-2225.
5. Rorsman, P. The pancreatic beta-cell as a fuel sensor: An electrophysiologist's viewpoint. Diabetologia 1997, 40, 487-495.
6. MacDonald, P.E.; El-Kholy, W.; Riedel, M.J.; Salapatek, A.M.; Light, P.E.; Wheeler, M.B. The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion. Diabetes 2002, 51 (Suppl. 3), S434-S442.
7. Leech, C.A.; Dzhura, I.; Chepurny, O.G.; Kang, G.; Schwede, F.; Genieser, H.G.; Holz, G.G. Molecular physiology of glucagon-like peptide-1 insulin secretagogue action in pancreatic beta cells. Prog. Biophys. Mol. Biol. 2011, 107, 236-247.
8. Furman, B.; Ong, W.K.; Pyne, N.J. Cyclic AMP signaling in pancreatic islets. Adv. Exp. Med. Biol. 2010, 654, 281-304.
9. MacDonald, M.J.; Fahien, L.A.; Brown, L.J.; Hasan, N.M.; Buss, J.D.; Kendrick, M.A. Perspective: Emerging evidence for signaling roles of mitochondrial anaplerotic products in insulin secretion. Am. J. Physiol. Endocrinol. Metab. 2005, 288, E1-E15.
10. Jensen, M.V.; Joseph, J.W.; Ronnebaum, S.M.; Burgess, S.C.; Sherry, A.D.; Newgard, C.B. Metabolic cycling in control of glucose-stimulated insulin secretion. Am. J. Physiol. Endocrinol. Metab. 2008, 295, E1287-E1297.
11. Ronnebaum, S.M.; Ilkayeva, O.; Burgess, S.C.; Joseph, J.W.; Lu, D.; Stevens, R.D.; Becker, T.C.; Sherry, A.D.; Newgard, C.B.; Jensen, M.V. A pyruvate cycling pathway involving cytosolic NADP-dependent isocitrate dehydrogenase regulates glucose-stimulated insulin secretion. J. Biol. Chem. 2006, 281, 30593-30602.
12. Joseph, J.W.; Jensen, M.V.; Ilkayeva, O.; Palmieri F.; Alarcon, C.; Rhodes, C.J.; Newgard, C.B. The mitochondrial citrate/isocitrate carrier plays a regulatory role in glucose-stimulated insulin secretion. J. Biol. Chem. 2006, 281, 35624-35632.
13. Ivarsson, R.; Quintens, R.; Dejonghe, S.; Tsukamoto, K.; in 't Veld, P.; Renstrom, E.; Schuit, F.C. Redox control of exocytosis: Regulatory role of NADPH, thioredoxin, and glutaredoxin. Diabetes 2005, 54, 2132-2142.
14. Reinbothe, T.M.; Ivarsson, R.; Li, D.Q.; Niazi, O.; Jing, X.; Zhang, E.; Stenson, L.; Bryborn, U.; Renstrom, E. Glutaredoxin-1 mediates NADPH-dependent stimulation of calcium-dependent insulin secretion. Mol. Endocrinol. 2009, 23, 893-900.
15. Lillig, C.H.; Berndt, C.; Holmgren, A. Glutaredoxin systems. Biochim. Biophys. Acta 2008, 1780, 1304-1317.
16. Ulrich, H.D. The SUMO system: An overview. Methods Mol. Biol. 2009, 497, 3-16.
17. Gareau, J.R.; Lima, C.D. The SUMO pathway: Emerging mechanisms that shape specificity, conjugation and recognition. Nat. Rev. Mol. Cell. Biol. 2010, 11, 861-871.
18. Kishi, A.; Nakamura, T.; Nishio, Y.; Maegawa, H.; Kashiwagi, A. Sumoylation of Pdx1 is associated with its nuclear localization and insulin gene activation. Am. J. Physiol. Endocrinol. Metab. 2003, 284, E830-E840.
19. Shao, C.; Cobb, M.H. Sumoylation regulates the transcriptional activity of MafA in pancreatic beta cells. J. Biol. Chem. 2009, 284, 3117-3124.
20. Martin, S.; Nishimune, A.; Mellor, J.R.; Henley, J.M. SUMOylation regulates kainate-receptor-mediated synaptic transmission. Nature 2007, 447, 321-325.
21. Feligioni, M.; Nishimune, A.; Henley, J.M. Protein SUMOylation modulates calcium influx and glutamate release from presynaptic terminals. Eur. J. Neurosci. 2009, 29, 1348-1356.
22. + channel K2P1. Cell 2005, 121, 37-47.
23. Benson, M.D.; Li, Q.J.; Kieckhafer, K.; Dudek, D.; Whorton, M.R.; Sunahara, R.K.; Iniguez-Lluhi, J.A.; Martens, J.R. SUMO modification regulates inactivation of the voltage-gated potassium channel Kv1.5. Proc. Natl. Acad. Sci. USA 2007, 104, 1805-1810.
24. Dai, X.Q.; Kolic, J.; Marchi, P.; Sipione, S.; Macdonald, P.E. SUMOylation regulates Kv2.1 and modulates pancreatic β-cell excitability. J. Cell Sci. 2009, 122, 775-779.
25. Plant, L.D.; Dowdell, E.J.; Dementieva, I.S.; Marks, J.D.; Goldstein, S.A. SUMO modification of cell surface Kv2.1 potassium channels regulates the activity of rat hippocampal neurons. J. Gen. Physiol. 2011, 137, 441-454.
26. Harder, Z.; Zunino, R.; McBride, H. Sumo1 conjugates mitochondrial substrates and participates in mitochondrial fission. Curr. Biol. 2004, 14, 340-345.
27. Zunino, R.; Schauss, A.; Rippstein, P.; Andrade-Navarro, M.; McBride, H.M. The SUMO protease SENP5 is required to maintain mitochondrial morphology and function. J. Cell Sci. 2007, 120, 1178-1188.
28. Braschi, E.; Zunino, R.; McBride, H.M. MAPL is a new mitochondrial SUMO E3 ligase that regulates mitochondrial fission. EMBO Rep. 2009, 10, 748-754.
29. Drag, M.; Salvesen, G.S. DeSUMOylating enzymes--SENPs. IUBMB Life 2008, 60, 734-742.
30. Kim, J.H.; Baek, S.H. Emerging roles of desumoylating enzymes. Biochim. Biophys. Acta 2009, 1792, 155-162.
31. Xu, Z.; Lam, L.S.; Lam, L.H.; Chau, S.F.; Ng, T.B.; Au, S.W. Molecular basis of the redox regulation of SUMO proteases: A protective mechanism of intermolecular disulfide linkage against irreversible sulfhydryl oxidation. FASEB J. 2008, 22, 127-137.
32. Xu, Z.; Chan, H.Y.; Lam, W.L.; Lam, K.H.; Lam, L.S.; Ng, T.B.; Au, S.W. SUMO proteases: Redox regulation and biological consequences. Antioxid. Redox. Signal. 2009, 11, 1453-1484.
33. Hayden, M.R.; Sowers, J.R. Isletopathy in Type 2 diabetes mellitus: Implications of islet RAS, islet fibrosis, islet amyloid, remodeling, and oxidative stress. Antioxid. Redox. Signal. 2007, 9, 891-910.
34. Ramirez, R.; Rasschaert, J.; Sener, A.; Malaisse, W.J. The coupling of metabolic to secretory events in pancreatic islets. Glucose-induced changes in mitochondrial redox state. Biochim. Biophys. Acta 1996, 1273, 263-267.
35. Dai, X.Q.; Plummer, G.; Casimir, M.; Kang, Y.; Hajmrle, C.; Gaisano, H.; Manning-Fox, J.; MacDonald, P. E. SUMOylation regulates insulin exocytosis downstream of secretory granule docking in rodents and humans. Diabetes 2011, 60, 838-847.
36. Rajan, S.; Torres, J.; Thompson, M.S.; Philipson, L.H. SUMO down-regulates GLP-1 stimulated cAMP generation and insulin secretion. Am. J. Physiol. Endocrinol. Metab. 2012, doi:10.1152/ajpendo.00486.201.
37. Rutter, G.A.; Hill, E.V. Insulin vesicle release: Walk, kiss, pause... then run. Physiology (Bethesda) 2006, 21, 189-196.
38. Rorsman, P.; Renstrom, E. Insulin granule dynamics in pancreatic beta cells. Diabetologia 2003, 46, 1029-1045.
39. Ehninger, A.; Mziaut, H.; Solimena, M. Emerging role of SUMO in pancreatic beta-cells. Horm. Metab. Res. 2007, 39, 658-664.
40. Baggio, L.L.; Drucker, D.J. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007, 132, 2131-2157.
41. + channel families regulate insulin secretion. Mol. Endocrinol. 2001, 15, 1423-1435.
42. + channels in pancreatic beta-cells enhances glucose-dependent insulin secretion. J. Biol. Chem. 2002, 277, 44938-44945.
43. Yan, L.; Figueroa, D.J.; Austin, C.P.; Liu, Y.; Bugianesi, R.M.; Slaughter, R.S.; Kaczorowski, G.J.; Kohler, M.G. Expression of voltage-gated potassium channels in human and rhesus pancreatic islets. Diabetes 2004, 53, 597-607.
44. Jacobson, D.A.; Kuznetsov, A.; Lopez, J.P.; Kash, S.; Ammala, C.E.; Philipson, L.H. Kv2.1 ablation alters glucose-induced islet electrical activity, enhancing insulin secretion. Cell Metab. 2007, 6, 229-235.
45. Dai, X.Q.; Manning Fox, J.E.; Chikvashvili, D.; Casimir, M.; Plummer, G.; Hajmrle, C.; Spigelman, A.F.; Kin, T.; Singer-Lahat, D.; Kang, Y.; et al. The Kv2.1 channel regulates insulin secretion from rodent and human islets independent of its electrical function. Diabetologia 2012, 55, 1709-1720.
46. + channel facilitation of exocytosis by dynamic interaction with syntaxin. J. Neurosci. 2007, 27, 1651-1658.
47. Gauthier, B.R.; Wollheim, C.B. Synaptotagmins bind calcium to release insulin. Am. J. Physiol. Endocrinol. Metab. 2008, 295, E1279-E1286.
48. Kanno, T.; Ma, X.; Barg, S.; Eliasson, L.; Galvanovskis, J.; Gopel, S.; Larsson, M.; Renstrom, E.; Rorsman, P. Large dense-core vesicle exocytosis in pancreatic beta-cells monitored by capacitance measurements. Methods 2004, 33, 302-311.
49. Jitrapakdee, S.; Wutthisathapornchai, A.; Wallace, J.C.; MacDonald, M.J. Regulation of insulin secretion: Role of mitochondrial signalling. Diabetologia 2010, 53, 1019-1032.
50. Pigeau, G.M.; Kolic, J.; Ball, B.J.; Hoppa, M.B.; Wang, Y.W.; Ruckle, T.; Woo, M.; Manning Fox, J.E.; Macdonald, P.E. Insulin granule recruitment and exocytosis is dependent on p110γ in insulinoma and human β-cells. Diabetes 2009, 58, 2084-2092.